Artwork

Content provided by Cabot Wealth Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cabot Wealth Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Bad Headlines, NFLX’s Suits Bump and Tesla Hits the Guardrails | Cabot Street Check

44:50
 
Share
 

Manage episode 380415182 series 3470620
Content provided by Cabot Wealth Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cabot Wealth Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, on Street Check, Chris and Brad discuss early earnings season results and the impact (if any) they're having on the market. Then they talk Eli Lilly (LLY) and Novo Nordisk's (NVO) blockbuster weight loss drugs and what knock-on effects they could have on other stocks and sectors. To close out the podcast, they briefly touch on the situation in Gaza and the potential impact on investors before discussing Brad's trip to Japan and (more importantly) the value of a favorable exchange rate when ticking items off your travel bucket list, whether Japan has turned the corner and is now a good investing destination, as well as a Japanese stock pick to take advantage of a recovering travel sector. Email Street Check at streetcheck@cabotwealth.com with feedback, comments, or suggestions.

  continue reading

64 episodes

Artwork
iconShare
 
Manage episode 380415182 series 3470620
Content provided by Cabot Wealth Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cabot Wealth Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, on Street Check, Chris and Brad discuss early earnings season results and the impact (if any) they're having on the market. Then they talk Eli Lilly (LLY) and Novo Nordisk's (NVO) blockbuster weight loss drugs and what knock-on effects they could have on other stocks and sectors. To close out the podcast, they briefly touch on the situation in Gaza and the potential impact on investors before discussing Brad's trip to Japan and (more importantly) the value of a favorable exchange rate when ticking items off your travel bucket list, whether Japan has turned the corner and is now a good investing destination, as well as a Japanese stock pick to take advantage of a recovering travel sector. Email Street Check at streetcheck@cabotwealth.com with feedback, comments, or suggestions.

  continue reading

64 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide